New Rhein, based in Pennsylvania, backs life sciences companies at Series A and B, mostly leading rounds, with notable investments like Theranica and Biocartis.
4 people on the investing team, 2 of them partners who can make the call. Partners are listed first.
Work here and something is wrong? Ask for a correction.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckOne email when this firm shows new activity. Nothing else.
New Rhein reports entry at series a, series b.
New Rhein has not reported a check size.
Yes. New Rhein says it can lead.
Nayan Gregory Parekh (Founder and Managing Partner), Subhanu Saxena (Managing Partner).
No recent activity since September 2026.
Work at New Rhein? Claim or correct this profile.